• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】47358

【品名】[11-(4-piperidinylidene)-6,11-dihydro-5H-imidazo[2,1-b][3]benzazepin-3-yl]methanol

【CA登记号】

【 分 子 式 】C18H21N3O

【 分 子 量 】295.38436

【元素组成】C 73.19% H 7.17% N 14.23% O 5.42%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号:(V)

Condensation of 4-hydroxyphenylethanol (I) with 2-(chloromethyl)quinoline (II) in ethanolic KOH provided ether (III). The free hydroxyl group of (III) was then converted to the corresponding mesylate (IV) by treatment with methanesulfonyl chloride and Et3N. Alkylation of 11-(4-piperidinylidene)-6,11-dihydro-5H-imidazo[2,1-b][3]benzazepine-3-methanol (V) with mesylate (IV) in the presence of NaHCO3 gave adduct (VI). The primary alcohol of (VI) was oxidized to aldehyde (VII) using MnO2 in CH2Cl2. Finally, aldehyde (VII) was further oxidized to the title methyl ester by means of MnO2 in the presence of sodium cyanate in HOAc-MeOH.

1 Janssens, F.E.; Leenaerts, J.E.; Sommen, F.M.; Surleraux, D.L.N.G. (Janssen Pharmaceutica NV); Fused imidazole derivs. as multidrug resistance modulators. EP 0888352; JP 2000505477; US 6218381; WO 9734897 .
2 Snoeck, H.J.M. (Janssen Pharmaceutica NV); Fused imidazole derivs. for improving oral bioavailability of pharmaceutical agents. WO 9913871 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 47355 4-(2-hydroxyethyl)phenol 501-94-0 C8H10O2 详情 详情
(II) 13162 2-(Chloromethyl)quinoline; alpha-Chloroquinaldine 4377-41-7 C10H8ClN 详情 详情
(III) 47356 2-[4-(2-quinolinylmethoxy)phenyl]-1-ethanol C18H17NO2 详情 详情
(IV) 47357 4-(2-quinolinylmethoxy)phenethyl methanesulfonate C19H19NO4S 详情 详情
(V) 47358 [11-(4-piperidinylidene)-6,11-dihydro-5H-imidazo[2,1-b][3]benzazepin-3-yl]methanol C18H21N3O 详情 详情
(VI) 47359 (11-[1-[4-(2-quinolinylmethoxy)phenethyl]-4-piperidinylidene]-6,11-dihydro-5H-imidazo[2,1-b][3]benzazepin-3-yl)methanol C36H36N4O2 详情 详情
(VII) 47360 11-[1-[4-(2-quinolinylmethoxy)phenethyl]-4-piperidinylidene]-6,11-dihydro-5H-imidazo[2,1-b][3]benzazepine-3-carbaldehyde C36H34N4O2 详情 详情
Extended Information